| ¿µ¹® | skin dose | ÇÑ±Û | ÇǺμ±·® |
|---|---|---|---|
| ¼³¸í | 1. ÇǺÎÇ¥¸é¿¡¼ÀÇ ¹æ»ç¼±ÀÇ °øÁß¼±·®À¸·Î ¿©±â¿¡´Â 1Â÷¹æ»ç¼±°ú ÈĹæ»ê¶õÀÌ Æ÷ÇԵȴÙ. 2. ÇǺο¡ Èí¼öµÇ´Â ¼±·®. |
||
| ¿µ¹® | radiation dose | ÇÑ±Û | ¹æ»ç¼±·® |
|---|---|---|---|
| ¼³¸í | ¹æ»ç¼±Á¶»çÀÇ Á¤µµ. ¹æ»ç¼±»ý¹°ÇÐÀ̳ª ÀÎüÀÇ ¹æ»ç¼±¹æÈ£¿¡¼´Â Àü¸®¹æ»ç¼±ÀÇ ¾ç, Áï ¼±·®ÀÌ ¹®Á¦°¡ µÈ´Ù. ¹æ»ç¼±·®¿¡¼µµ ±¹Á¦´ÜÀ§°è(SI)°¡ ä¿ëµÇ¾î ±¹Á¦¹æ»ç¼±¹æÈ£À§¿øÈ¸(ICRP)ÀÇ ±Ç°í¿¡ µû¶ó¼ ´ÙÀ½ÀÇ ¿©·¯ ´ÜÀ§°¡ ³Î¸® »ç¿ëµÈ´Ù. ¨ç Èí¼ö¼±·®(absorbed dose). ¹°ÁúÀÇ ´ÜÀ§Áú·®ÀÌ ¹æ»ç¼±¿¡ ÀÇÇØ ¹Þ¾ÆµéÀÌ´Â ¿¡³ÊÁö. ÀÌ ´ÜÀ§´Â ¹æ»ç¼± ¹× ¹°ÁúÀÇ Á¾·ù°¡ ¾î¶°ÇÑ °ÍÀÌ´õ¶óµµ »ç¿ëÇÒ ¼ö ÀÖ´Ù. ±¹Á¦´ÜÀ§´Â J/kgÀ̸ç À̰Ϳ¡ °íÀ¯ÇÑ ¸íĪÀ¸·Î ±×·¹ÀÌ(gray, ±âÈ£ Gy)°¡ ºÎ¿©µÈ´Ù. 1Gy=100¶óµå(rad). ¨è Á¶»ç¼±·®(exposure) ¶Ç´Â °øÁß¼±·®. X¼± ¶Ç´Â ¥ã¼±¿¡ ÇÑÇØ¼ »ç¿ëµÈ´Ù. ±¹Á¦´ÜÀ§´Â C/kg. ¨é ¼±·®´ç·®(dose equivalent). ¹æ»ç¼±¹æÈ£¸¦ À§ÇØ »ç¿ëµÇ´Â ¾ç. ±âÈ£´Â H. H´Â ¹æ»ç¼±ÀÇ Á¾·ù¿Í ¿¡³ÊÁö¿¡ ÀÇÇØ »ýü¿¡ ÁÖ´Â È¿°ú¸¦ º¸Á¤ÇÏ´Â ¼±Áú°è¼ö(Q)¿Í ±× ¹ÛÀÇ ÀÎÀÚ(¿¹¸¦ µé¸é ¼±·®·ü, ¹æ»ç¼ºµ¿À§¿ø¼Ò¿¡ ÀÇÇÑ ³»ºÎÇÇÆø½Ã¿¡´Â ±× ÇÙÁ¾ÀÇ Ã¼³»ºÐÆ÷ µî)¿¡ ±Ù°ÅÇÑ º¸Á¤°è¼ö(N)¸¦ Èí¼ö¼±·®(D)¿¡ °öÇÑ °Í, Áï H=D-Q-N. ¶ÇÇÑ DÀÇ ´ÜÀ§¸¦ Gy ¶Ç´Â rad·Î Ç¥½ÃÇÏ¿´À» ¶§ HÀÇ ´ÜÀ§¸¦ °¢°¢ ½Ãº£¸£Æ®(sievert, ±âÈ£ Sv) ¹× ·½(rem)À̶ó°í ÇÑ´Ù. µû¶ó¼ 1 Sv=102rem. ÀϹÝÀûÀ¸·Î ´ÜÀ§½Ã°£´çÀÇ ¼±·®À» ¼±·®·ü(dose rate)À̶ó°í ÇÑ´Ù. |
||
| ¿µ¹® | dose | ÇÑ±Û | ¿ë·®, Åõ¿©·®, ¹æ»ç¼±·® |
|---|---|---|---|
| ¼³¸í | 1. ¾àÁ¦¸¦ ÇÑ ¹ø ¶Ç´Â ÇÏ·ç¿¡ »ç¿ëÇϰųª º¹¿ëÇÏ´Â ºÐ·®. 2. ¹°ÁúÀ̳ª Á¶Á÷¿¡ ´ëÇÑ ¹æ»ç¼±ÀÇ ÀÛ¿ë Á¤µµ¸¦ ³ªÅ¸³»´Â ¾ç. Áï, ¹æ»ç¼±·®À̶ó´Â °³³äÀº ¾î¶² ÇÑ Á¡¿¡ ÀÔ»çÇÏ´Â ¹æ»ç¼±°ú ±× Á¡ ±Ùó¿¡ ÀÖ´Â ¹°Áú¿¡ ´ëÇÑ ¹æ»ç¼±ÀÇ ¹°¸®Àû-ÈÇÐÀû-»ý¹°ÇÐÀû È¿°ú¿ÍÀÇ °ü°Ô¸¦ Á¤·®ÀûÀ¸·Î ³ªÅ¸³»´Â °øÅëÀΠôµµ·Î¼ »ý°¢µÈ °ÍÀÌ´Ù. ¶óµå(rad)·Î ³ªÅ¸³»´Â Èí¼ö·®, ·»Æ®°Õ(R)À¸·Î ³ªÅ¸³»´Â Á¶»ç ¼±·®, ·½(rem)À¸·Î ³ªÅ¸³»´Â ¼±·® ´ç·®À¸·Î ±¸ºÐÇÏ¿© ¾´´Ù. |
||
| ¿µ¹® | basal layer of skin | ÇÑ±Û | ±âÀúÃþ |
|---|---|---|---|
| ¼³¸í | Ç¥ÇÇÀÇ °¡Àå ¾Æ·¡ ºÎºÐÀÌ¸ç ¼¼Æ÷ÀÇ ¸ð¾çÀÌ ºñ±³Àû Á÷»ç°¢Çü¿¡ °¡±õ°í ÀÏÁ¤ÇÑ ¹è¿À» ÇÑ´Ù. |
||
| ¿µ¹® | skin tag | ÇÑ±Û | ÁãÁ¥, ÇǺο¬¼º¼¶À¯Á¾ |
|---|---|---|---|
| ¼³¸í | ÁÖ·Î ¸ñ, °Üµå¶ûÀÌ, ´Ù¸®¿¡ »ý±â´Â »ì»ö ¶Ç´Â °ú»ö¼Ò Ä§Âø¼ºÀÇ ÀÛÀº ¸ñÀ» °¡Áø ¼¶À¯¼º µ¹Ãâ¹°·Î ´ë°³ ¹«Áõ»óÀÌ´Ù. |
||
| ¿µ¹® | skin | ÇÑ±Û | ÇǺΠ|
|---|---|---|---|
| ¼³¸í | ½Åü¸¦ ½Î°í ÀÖ´Â ¹Ù±ùÃþÀ¸·Î¼ Ç¥ÇÇ, ÁøÇÇ, ÇÇÇÏÁ¶Á÷À¸·Î ±¸¼ºµÇ¸ç, ¿ÜºÎ ȯ°æÀ¸·ÎºÎÅÍ ½Åü¸¦ º¸È£Çϰí ü¿ÂÀ» Á¶ÀýÇÏ´Â ±â´ÉÀ» °¡Áü. 1.Ç¥ÇÇ: ÇǺÎÀÇ °¡Àå ¹Ù±ùÃþÀ¸·Î¼ ¿Ü¹è¿±¿¡¼ ±â¿øÇÏ¸ç °¢ÁúÀ̶ó´Â ±¸Á¶ ´Ü¹éÁúÀ» »ý»êÇÏ´Â ±â´ÉÀ» °¡Áü. 4°¡ÁöÀÇ ¼¼Æ÷°¡ Àִµ¥, °¢Áú¼¼Æ÷, ¸á¶ó´Ñ¼¼Æ÷, Langerhans ¼¼Æ÷, ºÎÁ¤Çü ¼¼Æ÷, Merkel¼¼Æ÷°¡ ÀÖ´Ù. Ç¥ÇÇ¿¡´Â ÀÌ 4°¡Áö ¼¼Æ÷¿Ü¿¡ ´ÙÀ½°ú °°Àº Ç¥ÇÇ ºÎ¼Ó±â°¡ ÀÖ´Ù. ¿¡Å©¸° ¶¡»ù(eccrine sweat gland): Á¡¸· ÇǺΠ°æ°è ºÎÀ§ µî Ư¼öÇÑ ºÎÀ§¸¦ Á¦¿ÜÇÑ ¸ðµç ÇǺο¡¼ ¹ß°ßµÇ¸ç ¶¡À» ºÐºñÇÏ´Â »ùÀ¸·Î¼ ½Åü ¿ Á¶Àý ü°èÀÇ Áß¿äÇÑ ¿ä¼Ò. ¾ÆÆ÷Å©¸°»ù(apocrine gland): °Üµå¶ûÀÌ, Á¥²ÉÆÇ, Ç×¹® »ý½Ä±â ºÎÀ§, ¿ÜÀ̵µ, ´«²¨Ç® µî¿¡¼¸¸ ¹ß°ßµÇ¸ç ºÐºñ¹°ÀÇ ±â´ÉÀº Àß ¾Ë·ÁÁ® ÀÖÁö ¾ÊÀ¸³ª µ¿¹°¿¡¼´Â ¹æ¾î ¹× ¼ºÀû ±â´ÉÀÌ ÀÖÀ½. ÅÐÁÖ¸Ó´Ï(hair follicle): ¼Õ¹Ù´Ú, ¹ß¹Ù´Ú µî Ư¼ö ºÎÀ§¸¦ Á¦¿ÜÇÑ ½Åü Àü ºÎÀ§¿¡ ºÐÆ÷Çϸç Àΰ£¿¡¼ Áß¿äÇÑ »ý¸®Àû ±â´ÉÀº ¾øÀ¸³ª ¼ºÀû ¸Å·ÂÀ» Áö´Ï´Â ½Åü Àå½ÄÀÇ ±â´ÉÀ» °¡Áü. ±â¸§»ù(sebaceous gland): ¼Õ¹Ù´Ú°ú ¹ß¹Ù´ÚÀ» Á¦¿ÜÇÑ Àü ÇǺο¡ ºÐÆ÷ÇÏ¸ç ºÐºñ¹°À» ±â¸§(sebum)¶ó ºÎ¸§. ³²¼º È£¸£¸óÀÇ Àڱؿ¡ ÀÇÇØ ¼ºÀåÇÏ¸ç »ý¸®Àû ±â´ÉÀº Àß ¾Ë·ÁÁ® ÀÖÁö ¾ÊÀ½. ¼Õ¹ßÅé(nail) 2. ÁøÇÇ: Ç¥ÇÇ ¾Æ·¡¿¡ Á¸ÀçÇÏ´Â Á߹迱 ±â¿øÀÇ Á¶Á÷À¸·Î¼ Ç÷°ü, ¸²ÇÁ°ü, ½Å°æ, ±ÙÀ°, Ç¥ÇÇ ºÎ¼Ó±â µîÀ» Æ÷ÇÔÇϰí ÀÖÀ½. Ç¥ÇÇ ¹Ù·Î ¹ØÀÇ ºÎÀ§¸¦ À¯µÎ ÁøÇǶó ÇÏ°í ¾Æ·¡ÃþÀ» ¸Á»ó ÁøÇǶó ÇÑ´Ù. Á¶Á÷ ¼¶À¯¿¡´Â ¾Æ±³Áú ¼¶À¯, ±×¹° ¼¶À¯, ź·Â ¼¶À¯ÀÇ ¼¼ Á¾·ù°¡ ÀÖ´Ù. 3. ÇÇÇÏ Á¶Á÷: ÁøÇÇ ¾Æ·¡¿¡ Á¸ÀçÇϸç Á߹迱 ±â¿øÀ¸·Î¼ º¸¿Â ÀÛ¿ë, Ãæ°Ý Èí¼ö ÀÛ¿ë, ¿µ¾ç ÀúÀå ÀÛ¿ëÀÇ ±â´ÉÀÌ ÀÖ´Ù. |
||
| ID | identification; iditol dehydrogenase; immunodeficiency; immunodiffusion; immunoglobulin deficiency; ... |
|---|---|
| STD | selective T-cell defect; sexually transmitted disease; skin-to-tumor distance; skin test dose; sodiu... |
| TD | tabes dorsalis; tardive dyskinesia; T-cell dependent; temporary disability; terminal device; tetanus... |
| SD | Sandhoff disease; senile dementia; septal defect; serologically defined; serologically detectable; s... |
| CD | cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise... |
| CSS | Cultured skin substitutes |
|---|---|
| FST | Finger Skin Temperature |
| GSR | Galvanic Skin Resistance |
| GSR | Galvanic Skin Response |
| GSF | Genital skin fibroblast |
| skin dose | The quantity of radiation delivered to the skin surface. (05 Mar 2000) |
|---|
| absorbed dose | The amount of energy absorbed per unit mass of irradiated material at the target site; in radiation therapy, the former unit for absorbed dose is the rad; the current (S.I.) unit is the gray. (05 Mar 2000) |
|---|---|
| air dose | The radiation dose, expressed in roentgens, delivered at a point in free air. Synonym: air dose. (05 Mar 2000) |
| bone marrow dose | The cumulative dose to the blood-forming organ from therapeutic or nuclear fallout irradiation; the presumed leukemogenic dose. (05 Mar 2000) |
| booster dose | A dose given at some time after an initial dose to enhance the effect, said usually of antigens for the production of antibodies. (05 Mar 2000) |
| breast dose in mammography | <radiology> 180 mrad / view -- mid-breast dose, guideline: less than 1 rad for 2-view exam (12 Dec 1998) |
| maintenance dose | In chemotherapy, systematic dosage at a level that maintains protection against exacerbation. (05 Mar 2000) |
| genetically significant dose | <physics, radiobiology> The genetically significant dose is that which, if received by every member of the population, would be expected to produce the same genetic injury to the population as do the actual doses received by the individuals irradiated. Thus, the genetically significant dose is the dose equivalent to the gonads weighted for the age and sex distribution in those members of the irradiated population expected to have offspring. The genetically significant dose is expressed in sieverts (or rem). Acronym: GSD (06 Aug 1998) |
| maximal dose | <pharmacology> The largest amount of a drug or physical procedure that an adult can take with safety. (05 Mar 2000) |
| maximum permissible dose | <radiobiology> Defined by the International Commission on Radiological Protection as the greatest dose of radiation which, in the light of present knowledge, is not expected to cause detectable bodily injury to a person at any time during his lifetime. This dose has been reduced with each Commission report. The MPD is given in terms of acute or chronic exposure of the whole body or of organs, systems, or regions of the body, and differs for persons who are occupationally exposed versus the public at large. (05 Mar 2000) |
| median effective dose | The dose that produces the desired effect; when followed by a subscript (generally "ED50"), it denotes the dose having such an effect on a certain percentage (e.g., 50%) of the test animals; ED50 is the median effective dose, in radiation protection, the sum of the equivalent doses in all tissues and organs of the body weighted for tissue effects of radiation. The unit of effective dose is the sievert (Sv), epilation dose, the minimum amount of radiation sufficient to produce hair loss, usually in 10 to 14 days. (05 Mar 2000) |
| gonadal dose | The exposure dose to the male or female gonad, usually from incidental secondary radiation in diagnostic or therapeutic irradiation, or from whole-body irradiation. Synonym: gonadal dose. (05 Mar 2000) |
| gonad dose | The exposure dose to the male or female gonad, usually from incidental secondary radiation in diagnostic or therapeutic irradiation, or from whole-body irradiation. Synonym: gonadal dose. (05 Mar 2000) |
| minimal dose | <pharmacology> The smallest amount of a drug or physical procedure that will produce a desired physiologic effect in an adult. (05 Mar 2000) |
| minimal infecting dose | <microbiology> The smallest quantity of infectious material regularly producing infection; usually expressed as I.D.50, the quantity causing infection in 50% of a suitable series of animals or cells (cell cultures). (05 Mar 2000) |
| minimal lethal dose | <pharmacology> The minimal dose of a toxic substance or infectious agent that is lethal, as assayed in various experimental animals (e.g., the least amount of diphtheria toxin that, on an average, kills a 250-g guinea pig within 96 hours after subcutaneous inoculation). When followed by a subscript (generally "MLD50"), denotes the minimal dose that is lethal to a certain percentage (e.g., 50%) of animals so assayed, LD05. See: lethal dose. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|